why choose us

Clinical Trials Search

Showing 9,980 of 132,656 result(s)
Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Status: COMPLETED

Condition: Hepatitis B

Interventions: All participants are administered one tablet per day for 48 weeks

Date: 2023-07-14

Air Optix® Night and Day® Aqua Therapeutic Wear

Status: COMPLETED

Condition: Bullous Keratopathy

Interventions: CE-marked silicone hydrogel contact lenses

Date: 2023-07-14

Survival and Predictive Factors of Clinical Outcome in Patients With Acquired Brain Injury

Status: COMPLETED

Condition: Acquired Brain Injury

Interventions:

Date: 2023-07-13

Characteristics of Hoffa Adipose Tissue and Intramuscular Adipose Tissue in the Quadriceps Muscle

Status: Completed

Condition: Osteo Arthritis Knee

Interventions: biopsy

Date: 2023-07-13

A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases

Status: Completed

Condition: Allergic Disease

Interventions: Subcutaneous injection of YH35324

Date: 2023-07-13

The Effect of Fascia Iliaca Compartment Block (FICB) on QoR-15 Score in Partial Hip Arthroplasty Surgery

Status: COMPLETED

Condition: Post Operative Pain

Interventions: After the patients are in the supine position and aseptic conditions are provided in the preoperative period, the fascia on the iliacus muscle will be

Date: 2023-07-13

The Investigation of Underlying Mechanism of Lumbar Multifidus Muscle Activation Deficits

Status: COMPLETED

Condition: Low Back Pain

Interventions: The stimulation point is the lumbar multifidus hotspot.
The parameters will be set at frequency 10 Hz, 50 number of pulses, 40 train of stimulati

Date: 2023-07-13

A Single Dose, Phase 1 Study of YH35324 in Patients With Various Allergic Diseases

Status: COMPLETED

Condition: Allergic Disease

Interventions: Subcutaneous injection of YH35324

Date: 2023-07-13

Psycho-social Impact of Anti-NMDAR Encephalitis

Status: COMPLETED

Condition: NMDAR Antibody-associated Auto-immune Encephalitis

Interventions: To evaluate the cognitive and psycho-social long term impact of a NMDAR encephalitis, we will collect the data using specific interview assessments su

Date: 2023-07-13

High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment

Status: NOT_YET_RECRUITING

Condition: Myocardial Fibrosis

Interventions: Elucirem (Gadopiclenol) is a new macrocyclic gadolinium-based contrast agent (GBCA) with high relaxivity indicated for use in adults and children aged

Date: 2023-07-13